Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaolin Huang

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Critical Care (London, England)|May 16, 2020
Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional studyYuan Yu, Dan Xu, Shouzhi Fu, et al.
Lancet (London, England)|January 28, 2020
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaChaolin Huang, Yeming Wang, Xingwang Li, et al.
Frontiers in Medicine|January 11, 2021
Tracheostomy in 80 COVID-19 Patients: A Multicenter, Retrospective, Observational StudyYun Tang, Yongran Wu, Fangfang Zhu, et al.
The New England Journal of Medicine|January 17, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19Bin Cao, Yeming Wang, Hongzhou Lu, et al.
Lancet (London, England)|June 15, 2023
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
Lancet (London, England)|January 11, 2021
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Frontiers in Medicine|January 29, 2021
Extracorporeal Membrane Oxygenation for SARS-CoV-2 Acute Respiratory Distress Syndrome: A Retrospective Study From Hubei, ChinaXiaobo Yang, Ming Hu, Yuan Yu, et al.
The New England Journal of Medicine|March 19, 2020
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19Bin Cao, Yeming Wang, Danning Wen, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Critical Care (London, England)|May 16, 2020
Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional studyYuan Yu, Dan Xu, Shouzhi Fu, et al.
Lancet (London, England)|January 28, 2020
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaChaolin Huang, Yeming Wang, Xingwang Li, et al.
Frontiers in Medicine|January 11, 2021
Tracheostomy in 80 COVID-19 Patients: A Multicenter, Retrospective, Observational StudyYun Tang, Yongran Wu, Fangfang Zhu, et al.
The New England Journal of Medicine|January 17, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19Bin Cao, Yeming Wang, Hongzhou Lu, et al.
Lancet (London, England)|June 15, 2023
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
Lancet (London, England)|January 11, 2021
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Frontiers in Medicine|January 29, 2021
Extracorporeal Membrane Oxygenation for SARS-CoV-2 Acute Respiratory Distress Syndrome: A Retrospective Study From Hubei, ChinaXiaobo Yang, Ming Hu, Yuan Yu, et al.
The New England Journal of Medicine|March 19, 2020
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19Bin Cao, Yeming Wang, Danning Wen, et al.
Pageof 9